Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Latest filing published 19 Aug 2026 for Adaptive Biotechnologies Corp, €1.8M. Read the official filing
Filing timeline
BuySaleChad M. Robins
Insider track record
Disclosed buys
0
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Chad M. Robins: trading record in brief
Chad M. Robins is a declared insider of Adaptive Biotechnologies Corp (chief executive), with filings sourced from SEC (Form 4). Between 15 June 2021 and 18 August 2026, the trades on record add up to 29 filings.
On the market, this insider has only sold: 17 sales, €28.1M in total. Other entries cover 5 share grants and 7 option exercises. Since January 2026: no purchases and 9 sales on the market.
Most recently, on 19 August 2026, the filings show an open-market sale worth €6.9M in Adaptive Biotechnologies Corp. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Chad M. Robins
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
321,324 shares@ US$6.55Common StockSEC:0001780649-26-000014:0
318,799 shares@ US$25.08Common StockSEC:0001780649-26-000014:1
2,525 shares@ US$25.57Common StockSEC:0001780649-26-000014:2
278,676 shares@ US$6.55Common StockSEC:0001780649-26-000014:3
278,472 shares@ US$24.48Common StockSEC:0001780649-26-000014:4
204 shares@ US$25.14Common StockSEC:0001780649-26-000014:5
83,332 shares@ US$14.410.051% mcap5.9% of flowCommon StockSEC:0001780649-26-000011:0
140,567 shares@ US$13.178.2% of flowCommon StockSEC:0001780649-26-000007:0
127,813 shares0Common StockSEC:0001780649-26-000005:0
182,891 shares@ US$15.990.12% mcap14.1% of flowCommon StockSEC:0001780649-26-000003:0
124,998 shares@ US$18.440.095% mcap11.0% of flowCommon StockSEC:0001780649-26-000002:0
124,998 shares@ US$15.590.081% mcap9.4% of flowCommon StockSEC:0001780649-26-000001:0
35,736 shares@ US$19.680.030% mcap3.5% of flowCommon StockSEC:0001780649-25-000003:0
86,161 shares@ US$14.736.2% of flowCommon StockSEC:0001780649-25-000002:0
355,000 shares0Common StockSEC:0001062993-25-004809:0
186,080 shares@ US$6.324.4% of flowCommon StockSEC:0001062993-25-003241:0
158,921 shares@ US$6.323.8% of flowCommon StockSEC:0001062993-25-002744:2
158,921 shares@ US$8.465.1% of flowCommon StockSEC:0001062993-25-002744:3
100,287 shares@ US$6.322.4% of flowCommon StockSEC:0001062993-25-002744:0
100,287 shares@ US$8.443.2% of flowCommon StockSEC:0001062993-25-002744:1
211,160 shares@ US$6.325.0% of flowCommon StockSEC:0001062993-25-002744:4
211,160 shares@ US$8.506.7% of flowCommon StockSEC:0001062993-25-002744:5
354,610 shares0Common StockSEC:0001062993-24-005758:0
354,610 shares0Common StockSEC:0001062993-23-006321:0
14,815 shares@ US$6.320.4% of flowCommon StockSEC:0001209191-22-017696:0
25 of 29 declarations
